Practical Neurology

09/10/2025

Subcutaneous ( ) to be reviewed by U.S. Food and Drug Administration as a starting dose for people with early 's.
https://ow.ly/wVoG50WUaTo
Alzheimer's Association American Academy of Neurology (AAN) Eisai US Biogen

Eisai (Tokyo, Japan) and Biogen (Cambridge, MA) have initiated the rolling submission of a supplemental Biologics License Application (sBLA) to the Food a…

09/09/2025

age and type of menopausal hormone therapy were both linked to domains of memory performance in results of a study published in Neurology Journal.
https://ow.ly/nHTm50WUaxe
American Academy of Neurology (AAN) American College of Physicians (ACP) Alzheimer's Association

Results of a study published in Neurology suggest that the type of estradiol-based hormone therapy taken after menopause may be associated with specific d…

09/08/2025

The cover for our August issue was painted by Jean Sheakey through the Opening Minds through Art program, which partners a person with with a student to create intergenerational artwork.
https://ow.ly/ma7T50WTsuj
Alzheimer's Association American Academy of Neurology (AAN) Miami University Gerontological Society of America Opening Minds through Art (OMA)

About the Cover Artist: Ares by Jean Sheekey

09/05/2025

Dr. Cruz-Flores with E Zesati and D Silva-Mendoza explore the management of symptoms in vascular , such as mood disorders, behavior changes, & : https://ow.ly/oXiw50WN5r8
Saint Louis University School of Medicine Texas Tech Health El Paso Alzheimer's Association American Psychiatric Association

Neuropsychiatric symptoms associated with vascular dementia, including their underlying mechanisms, clinical implications, and potential management strate…

09/05/2025

The FDA rejected the New Drug Application for for the treatment of people with due to insufficient efficacy data.
https://ow.ly/kxMJ50WRySQ
PTC Therapeutics Friedreich's Ataxia News American Academy of Neurology (AAN)

The Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for vatiquinone (PTC Therapeutics, Warre…

09/04/2025

Results from phase 3 trial: Regeneron announces monotherapy significantly improved MG-ADL and QMG scores in adults with generalized vs placebo.
https://ow.ly/9sCx50WQL0Q
Myasthenia Gravis Foundation of America, Inc. American Association of Neuromuscular & Electrodiagnostic Medicine - AANEM National Multiple Sclerosis Society

New results from the phase 3 NIMBLE clinical trial (NCT05070858) show that study participants who received cemdisiran (Regeneron Pharmaceuticals, Tarrytow…

09/04/2025

Dr () discusses new from and on autologous hematopoietic stem cell transplantation for relapsing and in a new Masters episode: https://ow.ly/OAVU50WMZYr

09/04/2025

In a podcast episode, Dr. Song, Associate Professor of Radiology at Penn Medicine, discusses the diagnostic value, timing, and challenges of intracranial vessel wall MRI for .

Listen today: https://ow.ly/kank50WQKMw
ReachMD Endovascular Today Stroke AHA/ ASA

Jae W. Song, MD, MS, Associate Professor of Radiology at the University of Pennsylvania, Philadelphia, PA, discusses the diagnostic value of intracranial …

09/03/2025

How can clinicians manage , , and in those with 's? Drs. Goodland and Chand with L Vaikutis and EC DeMarco outline the approach to these complex and progressive symptoms: https://ow.ly/IMwx50WQIbB
American Psychiatric Association International Parkinson and Movement Disorder Society The Michael J. Fox Foundation for Parkinson's Research Saint Louis University School of Medicine Gerontological Society of America

09/03/2025

The U.S. Food and Drug Administration has accepted the Investigational New Drug application for , a proprietary biologic combination therapy for the treatment of .
https://ow.ly/xNf650WQHQv
The ALS Association American Association of Neuromuscular & Electrodiagnostic Medicine - AANEM American Academy of Neurology (AAN) Dr. Reddy's Laboratories Ltd.

The Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for COYA 302 (Coya Therapeutics, Houston, TX), a biologi…

09/02/2025

The U.S. Food and Drug Administration has approved subcutaneous for maintenance dosing after IV treatment. https://ow.ly/j2Es50WPUj6
Eisai Global Biogen Alzheimer's Association American Academy of Neurology (AAN) Gerontological Society of America

The Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for a subcutaneous formulation of lecanemab called Leqembi IQL…

09/01/2025

Practical Neurology's Notions Editor Peter Sguigna, MD spoke with Rachel Aubert, DO & Sergio Garces, MD about the diagnosis and treatment of retinal artery : https://ow.ly/4Isn50WN4Zu
UT Southwestern Medical Center Stroke AHA/ ASA American Heart Association Endovascular Today North American Neuro Ophthalmology Society (NANOS)

Developments in the diagnosis and treatment of retinal artery occlusion and the importance of collaboration between ophthalmologists and stroke neurologis…